JQ7-14379-45131
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 140 / NY
- Registered
- 2021-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-03
Dose 2 — Moderna
-
2021-12-21
Registered in v-safe
- 2021-12-21
- 2021-12-24
- 2022-01-02
- 2022-01-09
- 2022-01-14
-
2022-03-04
Survey response — 3 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Positive for Covid Jan 21stMedDRA releases: 2024-11 · check-in free text available
-
2022-03-04
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-08
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-03 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 3 months, dose 2
Symptoms: Positive for Covid Jan 21st
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release